Trial
NCT00714246
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Milton S. Hershey Medical Center
Collaborators
Sanofi
Condition
Non Small Cell Lung Cancer
Intervention
Bortezomib
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-24